INHALED DELIVERY OF PEPTIDE MIMICS OF CXCL10 FOR TARGETED ANTI-FIBROTIC THERAPY

摘要

Administration via inhalation of small peptides that mimic CXCL10 (FIBROKINE^TM peptides) is described. The peptides can be administered as an aerosol, such as an aerosol with a droplet size small enough to reach lung alveoli. Use of the peptides to treat fibrosis, such as lung fibrosis, is described.